Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 41 - 50 of 88 opportunities
The trypanosomatid parasitic diseases of Animal and Human African Trypanosomiasis (AAT and HAT) are the most serious livestock and human diseases on the African continent.
Researchers at the University of Glasgow have developed auto-fluorescence imaging to be incorporated into wireless devices for gastrointestinal diagnosis . The technology will significantly increase the diagnostic modality of these types of pill cameras, leading to improved patient outcomes.
A new type of Optoelectronic Integrated circuit (OEIC) has been developed at the University of Glasgow.
The University of Glasgow has developed novel Cardiac Imaging software to be used in existing Cardiac MRI equipment, automating the current process to reduce potential errors.
The University of Glasgow is offering an exciting new model for the evaluation of new treatments for Parkinsons disease
The University of Glasgow has developed a (Ad-hTR-NTR) which has been extensively tested on Ovarian cancer cells.
A polypeptide (TCP) has been identified by researchers at the University of Edinburgh that selectively captures Factor H, a key regulatory protein of the complement cascade. This discovery could be used to develop more sensitive and selective diagnostics for detecting Factor H and Factor H autoantib...
Inappropriate activation of the complement cascade is a significant cause of damage to implanted medical devices and stents. This polypeptide (TCP) that enhances the activity and protective properties of Factor H, a key regulator of the complement system. Surfaces coated with TCP molecules can prote...
This cattle‐specific vaccine delivery system can readily deliver and express antigens against a range of diseases that affect cattle, offering the potential to provide long term immunity and protection. It can also be used to deliver therapeutic proteins to improve productivity in cattle.
A new generation of broad-spectrum anti-influenza peptides with the scope to treat, as well as prevent, flu and a wider range of clinically relevant viral infections. These peptides have a novel mechanism of action, making them less likely to induce viral resistance and very effective at combatting ...